Literature DB >> 21750873

Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration.

Shu-Hua Xiao1, Jun Sun, Jian Xue, Xi-Ling Du, Hao-Bing Zhang.   

Abstract

The aim of the present study was to assess the ultrastructural alterations of juvenile Schistosoma japonicum induced by mefloquine. Mice infected with 14-day-old S. japonicum were treated orally with mefloquine at a single dose of 400 mg/kg. Between 8 h and 7 days after treatment, groups of two mice were sacrificed, and schistosomula were recovered for transmission electron microscopic observations. Ultrastructural damage was seen in the tegument, subtegumental musculature, parenchymal tissues, and gut epithelial cell. It was already prominent 8 h after drug administration and increased in severity rapidly to reach a peak 3 days post-treatment. Tegumental alterations were characterized by emergence of irregular and elongated cytoplasmic processes, which further fused together accompanied by indistinction of matrix and roughness of external plasma membrane. Meanwhile, in the subtegument, damage to the syncytium, swelling, and lysis of muscle bundles and parenchymal tissues were universal, which further aggravated the lesion on the tegument, followed by collapse or disintegration of damaged tegument to form numerous fragment or debris of cytoplasmic process detached from the worm surface. Severe damage to the gut epithelial cell was also observed 8 h post-mefloquine treatment, which included focal lysis of cytoplasm accompanied by formation of vacuoles and degeneration of mitochondria, emergence of enlarged and contracted nucleus with indistinct or focal disrupted nuclear membrane, and decrease in microvilli. All these alterations further increased in severity and reached the peak 3 days post-treatment. The findings of our study indicate that mefloquine exhibits a fast and potent ability to cause extensive ultrastructural damage to juvenile S. japonicum, which correlates with its high efficacy against juvenile schistosomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21750873     DOI: 10.1007/s00436-011-2534-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  31 in total

1.  Studies on prophylactic effect of artesunate on schistosomiasis japonica.

Authors:  S Li; L Wu; Z Liu; L Hu; P Xu; Y Xuan; Y Liu; X Liu; J Fan
Journal:  Chin Med J (Engl)       Date:  1996-11       Impact factor: 2.628

2.  [Relationship between the efficacy of praziquantel on rabbits infected with Schistosoma japonicum and the immune level of the host].

Authors:  S H Xiao; L S Qiu; G Z Wu; W J Yue; H C Xue; J Q You; H F Guo; G C Song; Y H Zhang
Journal:  Yao Xue Xue Bao       Date:  1986-10

3.  Antimalarials. 7. Bis(trifluoromethyl)- -(2-piperidyl)-4-quinolinemethanols.

Authors:  C J Ohnmacht; A R Patel; R E Lutz
Journal:  J Med Chem       Date:  1971-10       Impact factor: 7.446

4.  Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel.

Authors:  S H Xiao; W J Yue; Y Q Yang; J Q You
Journal:  Chin Med J (Engl)       Date:  1987-09       Impact factor: 2.628

5.  Tegumental alterations of adult Schistosoma japonicum harbored in mice treated with a single oral dose of mefloquine.

Authors:  Shu-hua Xiao; Jian Xue; Bing-gui Shen
Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi       Date:  2010-02

6.  Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.

Authors:  Luc Van Nassauw; Stephen Toovey; Joeri Van Op den Bosch; Jean-Pierre Timmermans; Jozef Vercruysse
Journal:  Travel Med Infect Dis       Date:  2008-08-08       Impact factor: 6.211

7.  Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice.

Authors:  Shu-Hua Xiao; Jacques Chollet; Jürg Utzinger; Jin-Yan Mei; Pei-Yin Jiao; Jennifer Keiser; Marcel Tanner
Journal:  Parasitol Res       Date:  2009-05-21       Impact factor: 2.289

8.  Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum.

Authors:  Shu-hua Xiao; Jing-yan Mei; Pei-ying Jiao
Journal:  Parasitol Res       Date:  2009-10-02       Impact factor: 2.289

9.  Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor.

Authors:  Maha-Hamadien Abdulla; Kee-Chong Lim; Mohammed Sajid; James H McKerrow; Conor R Caffrey
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

10.  Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target.

Authors:  Angela N Kuntz; Elisabeth Davioud-Charvet; Ahmed A Sayed; Lindsay L Califf; Jean Dessolin; Elias S J Arnér; David L Williams
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

View more
  4 in total

1.  Further studies on mefloquine and praziquantel alone or interaction of both drugs against Schistosoma japonicum in vitro.

Authors:  Shu-hua Xiao; Jian Xue; Hao-bing Zhang
Journal:  Parasitol Res       Date:  2011-08-19       Impact factor: 2.289

2.  Significance of higher drug concentration in erythrocytes of mice infected with Schistosoma japonicum and treated orally with mefloquine at single doses.

Authors:  Yi Tao; Jian Xue; Bin Jiang; Hao-Bing Zhang; Shu-Hua Xiao
Journal:  Parasitol Res       Date:  2015-09-04       Impact factor: 2.289

Review 3.  Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies.

Authors:  Shu-hua Xiao
Journal:  Parasitol Res       Date:  2013-08-27       Impact factor: 2.289

4.  In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum.

Authors:  Xiaoli Wang; Dan Yu; Chunxiang Li; Tingzheng Zhan; Tingting Zhang; Huihui Ma; Jing Xu; Chaoming Xia
Journal:  Parasit Vectors       Date:  2019-05-03       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.